Literature DB >> 29656949

Beginning the CAR T cell therapy revolution in the US and EU.

Stephan Grupp1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29656949     DOI: 10.1016/j.retram.2018.03.004

Source DB:  PubMed          Journal:  Curr Res Transl Med        ISSN: 2452-3186            Impact factor:   4.513


× No keyword cloud information.
  7 in total

Review 1.  CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies.

Authors:  Jian-Qing Mi; Jie Xu; Jianfeng Zhou; Weili Zhao; Zhu Chen; J Joseph Melenhorst; Saijuan Chen
Journal:  Front Med       Date:  2021-12-18       Impact factor: 4.592

2.  Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report.

Authors:  Meng-Yun Li; Zhi-Hong Lin; Ming-Ming Hu; Li-Qing Kang; Xiao-Xia Wu; Qi-Wei Chen; Xin Kong; Jian Zhang; Hui-Ying Qiu; De-Pei Wu
Journal:  Biomark Res       Date:  2020-08-31

Review 3.  Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies.

Authors:  Juliane Gust; Agne Taraseviciute; Cameron J Turtle
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

Review 4.  Cytokines in CAR T Cell-Associated Neurotoxicity.

Authors:  Juliane Gust; Rafael Ponce; W Conrad Liles; Gwenn A Garden; Cameron J Turtle
Journal:  Front Immunol       Date:  2020-12-16       Impact factor: 7.561

Review 5.  Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.

Authors:  Luca Falzone; Salvatore Salomone; Massimo Libra
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

6.  Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

Authors:  Ibrahim Yakoub-Agha; Christian Chabannon; Peter Bader; Grzegorz W Basak; Halvard Bonig; Fabio Ciceri; Selim Corbacioglu; Rafael F Duarte; Hermann Einsele; Michael Hudecek; Marie José Kersten; Ulrike Köhl; Jürgen Kuball; Stephan Mielke; Mohamad Mohty; John Murray; Arnon Nagler; Stephen Robinson; Riccardo Saccardi; Fermin Sanchez-Guijo; John A Snowden; Micha Srour; Jan Styczynski; Alvaro Urbano-Ispizua; Patrick J Hayden; Nicolaus Kröger
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

7.  Neurological updates: neurological complications of CAR-T therapy.

Authors:  Emma C Tallantyre; Nia A Evans; Jack Parry-Jones; Matt P G Morgan; Ceri H Jones; Wendy Ingram
Journal:  J Neurol       Date:  2020-11-02       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.